Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 24,989	$ 16,808
General and administrative	18,624	20,737
Loss on impairment of goodwill		29,517
Total operating expenses	43,613	67,062
Loss from operations	(43,613)	(67,062)
Other income (expense), net:
Interest and investment income	3,193	1,110
Other income (expense), net	3,193	1,110
Net loss	$ (40,420)	$ (65,952)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (3.57)	$ (5.86)
Weighted average shares outstanding, basic (in Shares)	11,331,338	11,259,615
Other comprehensive income (loss):
Net unrealized gain (loss) on marketable debt securities	$ 657	$ (477)
Other comprehensive income (loss)	657	(477)
Comprehensive loss	$ (39,763)	$ (66,429)